BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: El-Shabrawi MH, Sherief LM, Yakoot M, Kamal NM, Almalky MA, AbdElgawad MM, Mahfouz AA, Helmy S, Kamal EM, Attia D, El-Khayat HR. Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy. World J Clin Cases 2019; 7(16): 2247-2255 [PMID: 31531319 DOI: 10.12998/wjcc.v7.i16.2247]
URL: https://www.wjgnet.com/1948-5182/full/v7/i16/2247.htm
Number Citing Articles
1
Giuseppe Indolfi, Philippa Easterbrook, Sabrina Giometto, Farihah Malik, Roger Chou, Ersilia Lucenteforte. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysisLiver International 2024; 44(3): 663 doi: 10.1111/liv.15827
2
Michael Evan Rogers, William F Balistreri. Cascade of care for children and adolescents with chronic <NewLine />hepatitis CWorld Journal of Gastroenterology 2021; 27(12): 1117-1131 doi: 10.3748/wjg.v27.i12.1117
3
Treatment of hepatitis C in a case of pediatric B-cell acute leukemiaJournal of Global Infectious Diseases 2022; 14(1): 35 doi: 10.4103/jgid.jgid_1_21
4
Ashraf A. Tabll, Mamdouh S. Afifi, Abd-Allah S. El-Etrawy, Salah M. El-Kousy, Martina Smolic, Yasmine S. El Abd. CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antiviralsHuman Antibodies 2020; 28(2): 141 doi: 10.3233/HAB-190400
5
Jonathan R. Honegger, Charitha Gowda. Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in childrenCurrent Opinion in Infectious Diseases 2022; 35(5): 468 doi: 10.1097/QCO.0000000000000856
6
Giuseppe Indolfi, Sabrina Giometto, Daniele Serranti, Alessandra Bettiol, Elisabetta Bigagli, Salvatore De Masi, Ersilia Lucenteforte. Systematic review with meta‐analysis: the efficacy and safety of direct‐acting antivirals in children and adolescents with chronic hepatitis C virus infectionAlimentary Pharmacology & Therapeutics 2020; 52(7): 1125 doi: 10.1111/apt.16037
7
Guiseppe Indolfi, Deirdre Kelly, Gabriella Nebbia, Raffaele Iorio, Anna Mania, Vania Giacomet, Leszek Szenborn, Jiang Shao, Mun Sang Yue, Chia‐Hsiang Hsueh, Bandita Parhy, Kathryn Kersey, Alessandra Mangia, Malgorzata Pawlowska, Sanjay Bansal. Sofosbuvir‐velpatasvir‐voxilaprevir in adolescents 12 to 17 years old with HCV infectionHepatology 2022; 76(2): 445 doi: 10.1002/hep.32393
8
Othman AbouBakr, Mohammed Ezz El Regal, Amr Ali Sarhan, Maysaa El Sayed Zaki, Ahmed Noaman. Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with ComorbiditiesPediatric Drugs 2022; 24(5): 529 doi: 10.1007/s40272-022-00522-1
9
Mohammad Chehelgerdi, Matin Chehelgerdi. The use of RNA-based treatments in the field of cancer immunotherapyMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01807-w
10
Emanuele Nicastro, Lorenzo Norsa, Angelo Di Giorgio, Giuseppe Indolfi, Lorenzo D'Antiga. Breakthroughs and challenges in the management of pediatric viral hepatitisWorld Journal of Gastroenterology 2021; 27(20): 2474-2494 doi: 10.3748/wjg.v27.i20.2474